Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2011-12-12

Clinical Trial Update: Docetaxel and Oxaliplatin Combination With Locally Advanced or Metastatic Biliary Tract Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating a docetaxel plus oxaliplatin regimen for biliary tract cancer; the current status of the study is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • DOCETAXEL (DOCETAXEL)
  • OXALIPLATIN (Oxaliplatin)

Snippet

Sponsor: Korean South West Oncology Group | Conditions: Biliary Tract Cancer | Phase 2 | Status: UNKNOWN